Myoview

Hypoperfusion, Coronary Disease, Heart Attack + 7 more
Treatment
20 Active Studies for Myoview

What is Myoview

TetrofosminThe Generic name of this drug
Treatment SummaryTetrofosmin is a chemical compound with two phosphorus atoms that is used with technetium Tc-99m as a radiopharmaceutical. It helps to identify areas of the body with high levels of uptake, which can indicate disease.
Myoviewis the brand name
image of different drug pills on a surface
Myoview Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Myoview
Tetrofosmin
1996
2

Effectiveness

How Myoview Affects PatientsThis drug has not been described. Please see reference [DB09160] for more information.
How Myoview works in the bodyTetrofosmin is used to diagnose heart issues because it is taken up by heart tissue. Once it is in the body, it is a type of fatty, charged substance that spreads and collects in healthy heart tissue.

When to interrupt dosage

The proposed dosage of Myoview is subject to the diagnosed affliction, like Myocardial Perfusion Imaging, Coronary Artery Disease (CAD) and Hypoperfusion. The dosage is contingent upon the method of delivery as recorded in the table beneath.
Condition
Dosage
Administration
Coronary Disease
0.35 mg, , 1.38 mg, 0.23 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Myocardial Perfusion Imaging
0.35 mg, , 1.38 mg, 0.23 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Hypoperfusion
0.35 mg, , 1.38 mg, 0.23 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Heart Attack
0.35 mg, , 1.38 mg, 0.23 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Heart Disease
0.35 mg, , 1.38 mg, 0.23 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Left ventricular imaging
0.35 mg, , 1.38 mg, 0.23 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Mammography
0.35 mg, , 1.38 mg, 0.23 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Breast Cancer
0.35 mg, , 1.38 mg, 0.23 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Breast
0.35 mg, , 1.38 mg, 0.23 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous
Perfusion Scintigraphy
0.35 mg, , 1.38 mg, 0.23 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous

Warnings

Common Myoview Drug Interactions
Drug Name
Risk Level
Description
Myoview Toxicity & Overdose RiskStudies have not yet been done to investigate the toxicity of tetrofosmin.
image of a doctor in a lab doing drug, clinical research

Myoview Novel Uses: Which Conditions Have a Clinical Trial Featuring Myoview?

Currently, 784 active trials are examining the potential of Myoview to facilitate Perfusion Scintigraphy, Left Ventricular Imaging and Coronary Artery Disease (CAD) assessment.
Condition
Clinical Trials
Trial Phases
Breast
0 Actively Recruiting
Perfusion Scintigraphy
0 Actively Recruiting
Heart Disease
29 Actively Recruiting
Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4, Early Phase 1
Mammography
3 Actively Recruiting
Not Applicable
Myocardial Perfusion Imaging
1 Actively Recruiting
Phase 1
Left ventricular imaging
0 Actively Recruiting
Coronary Disease
1 Actively Recruiting
Not Applicable
Hypoperfusion
0 Actively Recruiting
Heart Attack
26 Actively Recruiting
Not Applicable, Phase 4, Phase 1, Phase 2, Early Phase 1, Phase 3
Breast Cancer
26 Actively Recruiting
Phase 2, Phase 1, Not Applicable

Myoview Reviews: What are patients saying about Myoview?

5Patient Review
9/14/2022
Myoview for Weight Loss Management for an Obese Person
I started at 199.6 pounds and, after seven months of using Wegovy, I am now down to 142.2. It's been four months since I stopped taking the medication and I'm still losing weight, which is amazing. The only downside is that it made me a little nauseous in the morning, but it was totally worth it for the results. And if you sign up for their training on the website, you can get a prescription card that will make it only $25 per month!
5Patient Review
8/13/2022
Myoview for Weight Loss Management for Overweight Person with BMI 27 to 29 and Weight-Related Comorbidity
This medication has helped me to finally feel full with smaller portions. I don't get shaky or irritated when I'm hungry, and I have lost 10% of my body weight in the first 5 months. I did have nausea and tiredness at first but after the first few months, I haven’t noticed it again.
5Patient Review
11/11/2022
Myoview for Weight Loss Management for Overweight Person with BMI 27 to 29 and Weight-Related Comorbidity
I experienced some diarrhea when I first started taking this medication, but it stopped after a few weeks.
5Patient Review
8/13/2022
Myoview for Weight Loss Management for an Obese Person
In just six months, I was able to lose 25 pounds with this medication. And the side effects were very minimal for me.
5Patient Review
8/29/2022
Myoview for Weight Loss Management for Overweight Person with BMI 27 to 29 and Weight-Related Comorbidity
I started taking Wegovy on October 2nd, 2021 weighing in at 313lbs. As of August 29th, 2022 I have lost 100lbs without changing my exercise habits! I experienced very few side effects.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about myoview

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is myoview used for?

"Myoview is a radioactive drug that helps doctors take pictures of the heart during exercise and at rest. The drug helps doctors see areas of the heart that are not getting enough blood flow. This can help doctors find out if there is a problem with the heart and if the heart is damaged."

Answered by AI

What is a myoview test?

"The stress test is used to help evaluate chest pain or shortness of breath. The test can also be used to detect the presence of early heart disease, or to assess a person's functional capacity or update the status of coronary circulation following a cardiac event."

Answered by AI

Is myoview radioactive?

"Radiation Safety:

Drug Handling: Technetium Tc99m tetrofosmin is a radioactive drug. Appropriate safety measures should be taken to minimize radiation exposure during administration [see WARNINGS AND PRECAUTIONS]."

Answered by AI

Is Tetrofosmin a myoview?

"The MYOVIEW kit is used to prepare an injectable solution of Technetium Tc99m tetrofosmin, a radioactive diagnostic agent."

Answered by AI

Clinical Trials for Myoview

Have you considered Myoview clinical trials? We made a collection of clinical trials featuring Myoview, we think they might fit your search criteria.
Have you considered Myoview clinical trials? We made a collection of clinical trials featuring Myoview, we think they might fit your search criteria.
Have you considered Myoview clinical trials? We made a collection of clinical trials featuring Myoview, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top